---
title: Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
date: '2023-09-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37773477/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230930180856&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Age-related macular degeneration (AMD) is a leading cause of severe vision
  loss worldwide, with a global prevalence that is predicted to substantially increase.
  Identifying early biomarkers indicative of progression risk will improve our ability
  to assess which patients are at greatest risk of progressing from intermediate AMD
  (iAMD) to vision-threatening late-stage AMD. This is key to ensuring individualized
  management and timely intervention before substantial structural damage. ...
disable_comments: true
---
Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk of progressing from intermediate AMD (iAMD) to vision-threatening late-stage AMD. This is key to ensuring individualized management and timely intervention before substantial structural damage. ...